Results 151 to 160 of about 5,953 (226)

Sofosbuvir/velpatasvir in treatment-experienced HCV-infected patients – short report [PDF]

, 2020
Anna Piekarska, Aleksandra Berkan‐Kawińska, Zbigniew Deroń, Justyna Ciupińska, Jolanta Białkowska   +4 more
openalex   +1 more source

Real-life study on the effectiveness and safety of sofosbuvir/velpatasvir-based antiviral agents for hepatitis C eradication in Chinese patients

Jiayi Wang, Lingyao Du, Dongmei Zhang, Chen Zhou, Yilan Zeng, Miao Liu, Xing Cheng, Xiaona Song, Han Chen, Ning Han, En‐Qiang Chen, Hong Tang   +11 more
openalex   +1 more source

Integrative multiomics dissection of LSM7 as a prognostic biomarker and therapeutic target in hepatocellular carcinoma. [PDF]

Sci Prog
Fan S, He Y, Ke P, Jiang J, Zhang S, Zeng D, Duan J, Wu M.   +7 more
europepmc   +1 more source

Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir [PDF]

, 2017
Zobair M. Younossi, Maria Stepanova, Stuart C. Gordon, Stefan Zeuzem, Michael P. Mann, Ira M. Jacobson, Marc Bourlière, Curtis Cooper, Steven L. Flamm, K. Rajender Reddy, Kris V. Kowdley, Issah Younossi, Sharon Hunt   +12 more
openalex   +1 more source

Necrolytic acral erythema in an incarcerated population: A case series. [PDF]

JAAD Case Rep
Ali I, Cavanagh M, Kelly BC.
europepmc   +1 more source

2025 KASL clinical practice guidelines for management of hepatitis C. [PDF]

Clin Mol Hepatol
Jang ES, Heo NY, Jeong JY, Park JG, Song DS, Cho EJ, Lee CH, Lee JS, Yoon JH, Han SK, Jung YK, Korean Association for the Study of the Liver (KASL).   +11 more
europepmc   +1 more source

New Drug: Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C [PDF]

, 2019
M Bourlire, S Gordon, S Flamm, C Cooper, A Ramji, M Tong, I Jacobson, E Lawitz, E Gane, B Willems, P Ruane, R Nahass   +11 more
openalex   +1 more source

[Recent Advances in the Treatment of Chronic Hepatitis C]. [PDF]

Korean J Gastroenterol
Kim SB.
europepmc   +1 more source

Virological characterization of patients with chronic hepatitis C and failure to a glecaprevir/pibrentasvir or voxilaprevir/ velpatasvir/sofosbuvir treatment in the international shared collaboration

, 2020
Adolfo de Salazar, Julia Dietz, Velia Chiara Di Maio, Slim Fourati, Beat Müllhaupt, Stefania Paolucci, Joaquín Cabezas, Rudolf Stauber, Nicola Coppola, Juan Arenas, Christiana Graf, Miguel Jiménez‐Pérez, Elisabetta Degasperi, J.M. Pascasio, Maria Paola Callegaro, Johannes Vermehren, José Miguel Rosales Zábal, Giovanni Battista Gaeta, Miguel García Deltoro, Heinz Zoller, Massimo Puoti, Christoph Berg, Mark W. Douglas, Jean–Michel Pawlotsky, A Howe, Féderico García, Francesca Ceccherini‐Silberstein, Christoph Sarrazin   +27 more
openalex   +1 more source

Clinical characteristics of patients with chronic hepatitis c infection at initial presentation to tertiary care in an Asian middle-income country [PDF]

, 2018
Azzeri, Amirah, Dahlui, Maznah, Kamarulzaman, Adeeba, McDonald, Scott A., Mohamed, Rosmawati, Shabaruddin, Fatiha Hana, Tan, Soek-Siam   +6 more
core